简体中文|English
Trial search Nation, Province(City) Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Recruiting status Register status Measure Ethical committee Study type
Funding source in Global project
Year：

None

Check the details 5(6.02%)

Self-funded

Check the details 5(6.02%)

The key project of the national key research and development plan

Check the details 4(4.82%)

Self-financing

Check the details 2(2.41%)

National Key Research and Development Program of China-2021YFC2501505

Check the details 2(2.41%)

Self-raised funds

Check the details 2(2.41%)

Guangdong Tempu Biochemical Pharmaceutical Co., LTD

Check the details 2(2.41%)

Key Project of the 2022 National Key Research and Development Program ''Active Health and Scientific Response to Population Aging''

Check the details 2(2.41%)

Chengdu First Pharmaceutical

Check the details 2(2.41%)

Chiatai Qingchunbao Pharmaceutical CO., LTD

Check the details 1(1.20%)

Chinese Neonatal Network

Check the details 1(1.20%)

Completely self-financed

Check the details 1(1.20%)

CSPC Pharmaceutical Group Co., Ltd.

Check the details 1(1.20%)

Eli Lilly, 5010 Program of Sun Yat-Sen University, Ministry of Health

Check the details 1(1.20%)

Excellent Research Ward of Beijing Municipal Health Commission

Check the details 1(1.20%)

Funds raised by oneself

Check the details 1(1.20%)

MicroPort Scientific Corporation

Check the details 1(1.20%)

"12.5" Project of China

Check the details 1(1.20%)

1. The National Science Fund for Distinguished Young Scholars ( No. 82025013) 2. The Chinese Academy of Medical Sciences Initiative for Innovative Medicine( No.2022-I2M-1-001) 3. The National High Level Hospital Clinical Research Funding ( No.2022-PUMCH-C-001)

Check the details 1(1.20%)

11th National Five-Year Plan + Sponsorship

Check the details 1(1.20%)

AstraZeneca Investment (China) Co., Ltd.

Check the details 1(1.20%)

Baotou Chinese Medicine Limited Liability Company

Check the details 1(1.20%)

Beijing Bethune Public Welfare Foundation

Check the details 1(1.20%)

Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. Hangzhou Tianlong Pharmaceutical Co., Ltd.

Check the details 1(1.20%)

Lelandh Biotech (Suzhou) CO.,LTD

Check the details 1(1.20%)

Medtronic, Inc

Check the details 1(1.20%)

National Administration of Traditional Chinese Medicine Special Fund for Improving Evidence-Based Ability of Specialty Diseases (2019XZZX-GK006)

Check the details 1(1.20%)

National high-tech research development plan (863 plan)

Check the details 1(1.20%)

Hospital funding

Check the details 1(1.20%)

Hospital level project

Check the details 1(1.20%)

It is partly funded by Health and Family Planning Commission of Hebei and the rest is self-financing.

Check the details 1(1.20%)

Jiangsu Kangrong Pharmaceutical Co., Ltd.

Check the details 1(1.20%)

Peking Union Medical College Hospital Central High Level Hospital Clinical Research Special Clinical Research Project: Key Cultivation Plan

Check the details 1(1.20%)

Pfizer Inc

Check the details 1(1.20%)

Qilu Pharmaceutical Co. , Ltd.

Check the details 1(1.20%)

Qilu Pharmaceutical Co., Ltd.

Check the details 1(1.20%)

raise independently

Check the details 1(1.20%)

Research Grant of the Ministry of Science and Technology, China

Check the details 1(1.20%)

Sanofi Pasteur; Chinese Society of Cardiology (CSC)

Check the details 1(1.20%)

self supported

Check the details 1(1.20%)

self-finance

Check the details 1(1.20%)

Self-selected topic (self-funded)

Check the details 1(1.20%)

Shanghai Huihe Medical Technology Co., Ltd.

Check the details 1(1.20%)

Shanghai Lebangda Pharmaceutical Technology Co., Ltd.

Check the details 1(1.20%)

Shanghai Children's Health Foundation

Check the details 1(1.20%)

Sichuan Medical Science and Technology Transformation and Development Foundation

Check the details 1(1.20%)

Special project for clinical research in the Second Affiliated Hospital of the Army Medical University (Project No.: 2024F046)

Check the details 1(1.20%)

Sponsor

Check the details 1(1.20%)

Stroke prevention project committee in National health commission of the People`s Republic of China

Check the details 1(1.20%)

Subsidize by SiChuan biokin pharmaceutical CO.,LTD

Check the details 1(1.20%)

Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program

Check the details 1(1.20%)

the Capital Medical Development Foundation No.2007-1043

Check the details 1(1.20%)

the Ministry of National Education

Check the details 1(1.20%)

the Special Public Welfare Industry Research of the National Health and Family Planning Commission

Check the details 1(1.20%)

National Natural Science Foundation of China, The first Young Talents Foundation of Hubei Province, Hubei Province health and family planning scientific research project

Check the details 1(1.20%)

National S&T Key Project for Infectious Diseases Control

Check the details 1(1.20%)

National S&T Major Project for Infectious Diseases Control

Check the details 1(1.20%)

National High Level Hospital Clinical Research Funding（2022-NHLHCRF-LX-01）

Check the details 1(1.20%)

National Key Research and Development Program of China（2018YFC2001900）

Check the details 1(1.20%)

No

Check the details 1(1.20%)

self-fund

Check the details 1(1.20%)

self-funding

Check the details 1(1.20%)

Tianjin Municipal Science and Technology Bureau

Check the details 1(1.20%)

Tianjin Science and Technology Project

Check the details 1(1.20%)

Xinjiang Production and Construction Corps 2024 Science and Technology Plan Project (No. 2024AB065)

Check the details 1(1.20%)

Xuanwu Hospital Capital Medical University

Check the details 1(1.20%)
欢迎访问WHO国际临床试验注册平台 Clinical Trials Hong Kong

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later